Selected research
Market Analysis & Forecast
Global Melphalan Injection Market Analysis and Forecast 2026-2032
Market perspective
The global Melphalan Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Melphalan Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Melphalan Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Melphalan Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Melphalan Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Melphalan Injection include Athenex, Dr. Reddy's, Mediclone Biotech, Meitheal Pharmaceutical, Par Pharmaceuticals, Sagent, Spectrum Pharmaceuticals, Fresenius Kabi and GSK, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Melphalan Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Melphalan Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Melphalan Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Melphalan Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Melphalan Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Melphalan Injection sales, projected growth trends, production technology, application and end-user industry.
Melphalan Injection Segment by Company
Athenex
Dr. Reddy's
Mediclone Biotech
Meitheal Pharmaceutical
Par Pharmaceuticals
Sagent
Spectrum Pharmaceuticals
Fresenius Kabi
GSK
Mylan
Melphalan Injection Segment by Type
50mg/vial
10mg/vial
Melphalan Injection Segment by Application
Recovery Center
Hospital
Clinics
Melphalan Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Melphalan Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Melphalan Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Melphalan Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Melphalan Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Melphalan Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Melphalan Injection sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50mg/vial
- 10mg/vial
Applications
- Recovery Center
- Hospital
- Clinics
Companies covered
- Athenex
- Dr. Reddy's
- Mediclone Biotech
- Meitheal Pharmaceutical
- Par Pharmaceuticals
- Sagent
- Spectrum Pharmaceuticals
- Fresenius Kabi
- GSK
- Mylan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Melphalan Injection Market by Type
- 1.2.1 Global Melphalan Injection Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 50mg/vial
- 1.2.3 10mg/vial
- 1.3 Melphalan Injection Market by Application
- 1.3.1 Global Melphalan Injection Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Recovery Center
- 1.3.3 Hospital
- 1.3.4 Clinics
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Melphalan Injection Market Dynamics
- 2.1 Melphalan Injection Industry Trends
- 2.2 Melphalan Injection Industry Drivers
- 2.3 Melphalan Injection Industry Opportunities and Challenges
- 2.4 Melphalan Injection Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Melphalan Injection Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Melphalan Injection Revenue by Region
- 3.2.1 Global Melphalan Injection Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Melphalan Injection Revenue by Region (2021-2026)
- 3.2.3 Global Melphalan Injection Revenue by Region (2027-2032)
- 3.2.4 Global Melphalan Injection Revenue Market Share by Region (2021-2032)
- 3.3 Global Melphalan Injection Sales Estimates and Forecasts 2021-2032
- 3.4 Global Melphalan Injection Sales by Region
- 3.4.1 Global Melphalan Injection Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Melphalan Injection Sales by Region (2021-2026)
- 3.4.3 Global Melphalan Injection Sales by Region (2027-2032)
- 3.4.4 Global Melphalan Injection Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Melphalan Injection Revenue by Manufacturers
- 4.1.1 Global Melphalan Injection Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Melphalan Injection Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Melphalan Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Melphalan Injection Sales by Manufacturers
- 4.2.1 Global Melphalan Injection Sales by Manufacturers (2021-2026)
- 4.2.2 Global Melphalan Injection Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Melphalan Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Melphalan Injection Sales Price by Manufacturers (2021-2026)
- 4.4 Global Melphalan Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Melphalan Injection Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Melphalan Injection Manufacturers, Product Type & Application
- 4.7 Global Melphalan Injection Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Melphalan Injection Market CR5 and HHI
- 4.8.2 2025 Melphalan Injection Tier 1, Tier 2, and Tier 3
5 Melphalan Injection Market by Type
- 5.1 Global Melphalan Injection Revenue by Type
- 5.1.1 Global Melphalan Injection Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Melphalan Injection Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Melphalan Injection Revenue Market Share by Type (2021-2032)
- 5.2 Global Melphalan Injection Sales by Type
- 5.2.1 Global Melphalan Injection Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Melphalan Injection Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Melphalan Injection Sales Market Share by Type (2021-2032)
- 5.3 Global Melphalan Injection Price by Type
6 Melphalan Injection Market by Application
- 6.1 Global Melphalan Injection Revenue by Application
- 6.1.1 Global Melphalan Injection Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Melphalan Injection Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Melphalan Injection Revenue Market Share by Application (2021-2032)
- 6.2 Global Melphalan Injection Sales by Application
- 6.2.1 Global Melphalan Injection Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Melphalan Injection Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Melphalan Injection Sales Market Share by Application (2021-2032)
- 6.3 Global Melphalan Injection Price by Application
7 Company Profiles
- 7.1 Athenex
- 7.1.1 Athenex Company Information
- 7.1.2 Athenex Business Overview
- 7.1.3 Athenex Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Athenex Melphalan Injection Product Portfolio
- 7.1.5 Athenex Recent Developments
- 7.2 Dr. Reddy's
- 7.2.1 Dr. Reddy's Company Information
- 7.2.2 Dr. Reddy's Business Overview
- 7.2.3 Dr. Reddy's Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Dr. Reddy's Melphalan Injection Product Portfolio
- 7.2.5 Dr. Reddy's Recent Developments
- 7.3 Mediclone Biotech
- 7.3.1 Mediclone Biotech Company Information
- 7.3.2 Mediclone Biotech Business Overview
- 7.3.3 Mediclone Biotech Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Mediclone Biotech Melphalan Injection Product Portfolio
- 7.3.5 Mediclone Biotech Recent Developments
- 7.4 Meitheal Pharmaceutical
- 7.4.1 Meitheal Pharmaceutical Company Information
- 7.4.2 Meitheal Pharmaceutical Business Overview
- 7.4.3 Meitheal Pharmaceutical Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Meitheal Pharmaceutical Melphalan Injection Product Portfolio
- 7.4.5 Meitheal Pharmaceutical Recent Developments
- 7.5 Par Pharmaceuticals
- 7.5.1 Par Pharmaceuticals Company Information
- 7.5.2 Par Pharmaceuticals Business Overview
- 7.5.3 Par Pharmaceuticals Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Par Pharmaceuticals Melphalan Injection Product Portfolio
- 7.5.5 Par Pharmaceuticals Recent Developments
- 7.6 Sagent
- 7.6.1 Sagent Company Information
- 7.6.2 Sagent Business Overview
- 7.6.3 Sagent Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Sagent Melphalan Injection Product Portfolio
- 7.6.5 Sagent Recent Developments
- 7.7 Spectrum Pharmaceuticals
- 7.7.1 Spectrum Pharmaceuticals Company Information
- 7.7.2 Spectrum Pharmaceuticals Business Overview
- 7.7.3 Spectrum Pharmaceuticals Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Spectrum Pharmaceuticals Melphalan Injection Product Portfolio
- 7.7.5 Spectrum Pharmaceuticals Recent Developments
- 7.8 Fresenius Kabi
- 7.8.1 Fresenius Kabi Company Information
- 7.8.2 Fresenius Kabi Business Overview
- 7.8.3 Fresenius Kabi Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Fresenius Kabi Melphalan Injection Product Portfolio
- 7.8.5 Fresenius Kabi Recent Developments
- 7.9 GSK
- 7.9.1 GSK Company Information
- 7.9.2 GSK Business Overview
- 7.9.3 GSK Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 GSK Melphalan Injection Product Portfolio
- 7.9.5 GSK Recent Developments
- 7.10 Mylan
- 7.10.1 Mylan Company Information
- 7.10.2 Mylan Business Overview
- 7.10.3 Mylan Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Mylan Melphalan Injection Product Portfolio
- 7.10.5 Mylan Recent Developments
8 North America
- 8.1 North America Melphalan Injection Market Size by Type
- 8.1.1 North America Melphalan Injection Revenue by Type (2021-2032)
- 8.1.2 North America Melphalan Injection Sales by Type (2021-2032)
- 8.1.3 North America Melphalan Injection Price by Type (2021-2032)
- 8.2 North America Melphalan Injection Market Size by Application
- 8.2.1 North America Melphalan Injection Revenue by Application (2021-2032)
- 8.2.2 North America Melphalan Injection Sales by Application (2021-2032)
- 8.2.3 North America Melphalan Injection Price by Application (2021-2032)
- 8.3 North America Melphalan Injection Market Size by Country
- 8.3.1 North America Melphalan Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Melphalan Injection Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Melphalan Injection Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Melphalan Injection Market Size by Type
- 9.1.1 Europe Melphalan Injection Revenue by Type (2021-2032)
- 9.1.2 Europe Melphalan Injection Sales by Type (2021-2032)
- 9.1.3 Europe Melphalan Injection Price by Type (2021-2032)
- 9.2 Europe Melphalan Injection Market Size by Application
- 9.2.1 Europe Melphalan Injection Revenue by Application (2021-2032)
- 9.2.2 Europe Melphalan Injection Sales by Application (2021-2032)
- 9.2.3 Europe Melphalan Injection Price by Application (2021-2032)
- 9.3 Europe Melphalan Injection Market Size by Country
- 9.3.1 Europe Melphalan Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Melphalan Injection Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Melphalan Injection Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
- 9.3.9 Nordic Countries
10 China
- 10.1 China Melphalan Injection Market Size by Type
- 10.1.1 China Melphalan Injection Revenue by Type (2021-2032)
- 10.1.2 China Melphalan Injection Sales by Type (2021-2032)
- 10.1.3 China Melphalan Injection Price by Type (2021-2032)
- 10.2 China Melphalan Injection Market Size by Application
- 10.2.1 China Melphalan Injection Revenue by Application (2021-2032)
- 10.2.2 China Melphalan Injection Sales by Application (2021-2032)
- 10.2.3 China Melphalan Injection Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Melphalan Injection Market Size by Type
- 11.1.1 Asia Melphalan Injection Revenue by Type (2021-2032)
- 11.1.2 Asia Melphalan Injection Sales by Type (2021-2032)
- 11.1.3 Asia Melphalan Injection Price by Type (2021-2032)
- 11.2 Asia Melphalan Injection Market Size by Application
- 11.2.1 Asia Melphalan Injection Revenue by Application (2021-2032)
- 11.2.2 Asia Melphalan Injection Sales by Application (2021-2032)
- 11.2.3 Asia Melphalan Injection Price by Application (2021-2032)
- 11.3 Asia Melphalan Injection Market Size by Country
- 11.3.1 Asia Melphalan Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Melphalan Injection Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Melphalan Injection Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Melphalan Injection Market Size by Type
- 12.1.1 SAMEA Melphalan Injection Revenue by Type (2021-2032)
- 12.1.2 SAMEA Melphalan Injection Sales by Type (2021-2032)
- 12.1.3 SAMEA Melphalan Injection Price by Type (2021-2032)
- 12.2 SAMEA Melphalan Injection Market Size by Application
- 12.2.1 SAMEA Melphalan Injection Revenue by Application (2021-2032)
- 12.2.2 SAMEA Melphalan Injection Sales by Application (2021-2032)
- 12.2.3 SAMEA Melphalan Injection Price by Application (2021-2032)
- 12.3 SAMEA Melphalan Injection Market Size by Country
- 12.3.1 SAMEA Melphalan Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Melphalan Injection Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Melphalan Injection Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Melphalan Injection Value Chain Analysis
- 13.1.1 Melphalan Injection Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Melphalan Injection Production Mode & Process
- 13.2 Melphalan Injection Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Melphalan Injection Distributors
- 13.2.3 Melphalan Injection Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst